Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Israeli Stocks: Israel Chemicals, Partner, Cellcom, Ampal

Jan. 8 (Bloomberg) -- Israel’s TA-25 Index gained for a sixth day, advancing 0.1 percent to 1,114.37, at 2:17 p.m. in Tel Aviv. The measure dropped 18 percent last year.

The following stocks rose or fell today. Symbols are in parentheses.

Ampal-American Israel Corp. (AMPL IT) surged 13 percent, the most since Nov. 14 in intraday trade, to 1.3870 shekels. Al-Ahram reported that Egypt and Israel are negotiating a new gas-export contract. The stock is up 18 percent since Al-Ahram published the report Jan. 3. Globes cited the Al-Ahram report today.

Israel Chemicals Ltd. (ICL IT) declined the most since Dec. 29, falling 2.3 percent to 39.36 shekels. The maker of fertilizer from minerals harvested from the Dead Sea said Chief Executive Officer Akiva Mozes will retire after 13 years in the position.

Cellcom Israel Ltd. (CEL IT) declined the most since Jan. 5, dropping 1.8 percent to 60.62 shekels, or the equivalent of $15.73. The shares in the country’s largest telecommunications company declined 0.9 percent to $15.51 in the U.S. on Jan. 6.

Partner Communications Co. (PTNR IT) lost 1.9 percent, the biggest intraday drop since Dec. 29, to 34.67 shekels. Controlling shareholder Ilan Ben-Dov, who owns 44 percent of Partner through Scailex Corp., said he intends to step down as chairman.

To contact the editor responsible for this story: Claudia Maedler at cmaedler@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.